Chao Ji
Academic / Other · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313. Pemphigus Disease, Pemphigus Vulgaris (PV) | Phase 1 / Phase 2 | 2025-10-01 |
| Enrolling By Invitation | A Real-World Study of Biologic Therapy for Subclinical Psoriatic Arthritis Subclinical Psoriatic Arthritis | — | 2023-11-01 |
| Completed | Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids Pemphigus, Pemphigus Vulgaris (PV) | — | 2023-01-01 |
| Completed | JAK Inhibitors' Efficacy in Bullous Pemphigoid Bullous Pemphigoid, Janus Kinase Inhibitor, Corticosteroids | — | 2022-01-01 |
| Completed | Biologic Therapy for Generalized Pustular Psoriasis Generalized Pustular Psoriasis | — | 2019-07-01 |
| Completed | SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs Immune Checkpoint Inhibitor-Induced Dermatitis, Stevens-Johnson Syndrome, Drug-Induced, Toxic Epidermal Necrolysis Due to Drug | — | 2015-01-01 |